Medicine and Health Sciences Commons^™

Anxiety Severity And Prescription Medication Utilization In First-Time Medical Marijuana Users, Karen L. Dugosh, Megan M. Short, Paulina Syracuse, Thomas R. Mccalmont, Michelle R. Lent

PCOM Scholarly Papers

Background

Anxiety and post-traumatic stress disorder (PTSD) are qualifying psychiatric conditions for medical marijuana (MM) treatment in Pennsylvania. This study examined baseline prevalence and changes in prescription anxiety medication use three months following MM treatment initiation among individuals with these qualifying conditions.

Methods

The study sample was comprised of 108 adults with anxiety or PTSD as a referring condition; they were enrolled in a longitudinal study evaluating biopsychosocial outcomes in new MM patients. Consenting participants completed an assessment battery at baseline and Month 3 (n = 94, 87 % follow-up rate) that included a measure of anxiety severity and …

Attitudes About Future Genetic Testing For Posttraumatic Stress Disorder And Addiction Among Community-Based Veterans., Michelle R. Lent, Stuart N Hoffman, H Lester Kirchner, Thomas G Urosevich, Joseph J Boscarino, Joseph A Boscarino

PCOM Scholarly Papers

This study explored attitudes toward hypothetical genetic testing for posttraumatic stress disorder (PTSD) and addiction among veterans. We surveyed a random sample of community-based veterans (n = 700) by telephone. One year later, we asked the veterans to provide a DNA sample for analysis and 41.9% of them returned the DNA samples. Overall, most veterans were not interested in genetic testing neither for PTSD (61.7%) nor for addiction (68.7%). However, bivariate analyses suggested there was an association between having the condition of interest and the likelihood of genetic testing on a 5-point scale (p < 0.001 for PTSD; p = 0.001 for …